[Articles] Effect of [68Ga]Ga-PSMA-11 PET-CT in the diagnosis of prostate cancer in men with equivocal or clinically high-risk non-suspicious findings on multiparametric MRI (PRIMARY2): a multicentre, non-inferiority, phase 3, randomised controlled trial

Journal content Created on 11 Jun 2026 The Lancet Oncology

• Details
• • All feed content
  • My feed content